Majorbio Cloud: A one-stop, comprehensive bioinformatic platform for multiomics analyses.

Autor: Ren Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Yu G; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Shi C; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Liu L; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Guo Q; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Han C; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhang D; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhang L; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Liu B; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Gao H; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zeng J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhou Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Qiu Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Wei J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Luo Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhu F; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Li X; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Wu Q; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Li B; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Fu W; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Tong Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Meng J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Fang Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Dong J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Feng Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Xie S; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Yang Q; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Yang H; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Wang Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhang J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Gu H; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Xuan H; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zou G; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Luo C; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Huang L; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Yang B; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Dong Y; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhao J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Han J; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Zhang X; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China., Huang H; Shanghai Majorbio Bio-pharm Technology Co., Ltd. Shanghai China.
Jazyk: angličtina
Zdroj: IMeta [Imeta] 2022 Mar 16; Vol. 1 (2), pp. e12. Date of Electronic Publication: 2022 Mar 16 (Print Publication: 2022).
DOI: 10.1002/imt2.12
Abstrakt: The platform consists of three modules, which are pre-configured bioinformatic pipelines, cloud toolsets, and online omics' courses. The pre-configured bioinformatic pipelines not only combine analytic tools for metagenomics, genomes, transcriptome, proteomics and metabolomics, but also provide users with powerful and convenient interactive analysis reports, which allow them to analyze and mine data independently. As a useful supplement to the bioinformatics pipelines, a wide range of cloud toolsets can further meet the needs of users for daily biological data processing, statistics, and visualization. The rich online courses of multi-omics also provide a state-of-art platform to researchers in interactive communication and knowledge sharing.
Competing Interests: The platform described in this manuscript is related to an authorized patent CN201810796979.6. Quan Guo, Guo Yu, Yi Ren, Lei Zhang, Yong Zhou, Xianglin Zhang, and Huasheng Huang are inventors of the patent. Huasheng Huang and Xianglin Zhang are cofounders of Majorbio. The other authors are employees of Majorbio.
(© 2022 The Authors. iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.)
Databáze: MEDLINE
Externí odkaz: